Pharma & Healthcare
Global Kidney (Renal) Fibrosis Market Research Report 2025
- Sep 09, 25
- ID: 497252
- Pages: 76
- Figures: 73
- Views: 5
This report aims to provide a comprehensive presentation of the global market for Kidney (Renal) Fibrosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney (Renal) Fibrosis.
The Kidney (Renal) Fibrosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Kidney (Renal) Fibrosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kidney (Renal) Fibrosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Pfizer
Roche
InterMune
Galectin Therapeutics
La Jolla Pharmaceutical Company
ProMetic Life-Sciences Inc.
BioLine Rx Ltd
Genzyme Corporation
Segment by Type
Angiotensin Converting enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasopeptidase Inhibitors
Segment by Application
Research Center
Hospital
Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney (Renal) Fibrosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Kidney (Renal) Fibrosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Kidney (Renal) Fibrosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kidney (Renal) Fibrosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Pfizer
Roche
InterMune
Galectin Therapeutics
La Jolla Pharmaceutical Company
ProMetic Life-Sciences Inc.
BioLine Rx Ltd
Genzyme Corporation
Segment by Type
Angiotensin Converting enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasopeptidase Inhibitors
Segment by Application
Research Center
Hospital
Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney (Renal) Fibrosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney (Renal) Fibrosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Angiotensin Converting enzyme (ACE) Inhibitors
1.2.3 Pirfenidone
1.2.4 Renin Inhibitors
1.2.5 Angiotensin II Receptor Blockers (ARBs)
1.2.6 Vasopeptidase Inhibitors
1.3 Market by Application
1.3.1 Global Kidney (Renal) Fibrosis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Kidney (Renal) Fibrosis Market Perspective (2020-2031)
2.2 Global Kidney (Renal) Fibrosis Growth Trends by Region
2.2.1 Global Kidney (Renal) Fibrosis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Kidney (Renal) Fibrosis Historic Market Size by Region (2020-2025)
2.2.3 Kidney (Renal) Fibrosis Forecasted Market Size by Region (2026-2031)
2.3 Kidney (Renal) Fibrosis Market Dynamics
2.3.1 Kidney (Renal) Fibrosis Industry Trends
2.3.2 Kidney (Renal) Fibrosis Market Drivers
2.3.3 Kidney (Renal) Fibrosis Market Challenges
2.3.4 Kidney (Renal) Fibrosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kidney (Renal) Fibrosis Players by Revenue
3.1.1 Global Top Kidney (Renal) Fibrosis Players by Revenue (2020-2025)
3.1.2 Global Kidney (Renal) Fibrosis Revenue Market Share by Players (2020-2025)
3.2 Global Kidney (Renal) Fibrosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Kidney (Renal) Fibrosis Revenue
3.4 Global Kidney (Renal) Fibrosis Market Concentration Ratio
3.4.1 Global Kidney (Renal) Fibrosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney (Renal) Fibrosis Revenue in 2024
3.5 Global Key Players of Kidney (Renal) Fibrosis Head office and Area Served
3.6 Global Key Players of Kidney (Renal) Fibrosis, Product and Application
3.7 Global Key Players of Kidney (Renal) Fibrosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney (Renal) Fibrosis Breakdown Data by Type
4.1 Global Kidney (Renal) Fibrosis Historic Market Size by Type (2020-2025)
4.2 Global Kidney (Renal) Fibrosis Forecasted Market Size by Type (2026-2031)
5 Kidney (Renal) Fibrosis Breakdown Data by Application
5.1 Global Kidney (Renal) Fibrosis Historic Market Size by Application (2020-2025)
5.2 Global Kidney (Renal) Fibrosis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Kidney (Renal) Fibrosis Market Size (2020-2031)
6.2 North America Kidney (Renal) Fibrosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Kidney (Renal) Fibrosis Market Size by Country (2020-2025)
6.4 North America Kidney (Renal) Fibrosis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Kidney (Renal) Fibrosis Market Size (2020-2031)
7.2 Europe Kidney (Renal) Fibrosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Kidney (Renal) Fibrosis Market Size by Country (2020-2025)
7.4 Europe Kidney (Renal) Fibrosis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Kidney (Renal) Fibrosis Market Size (2020-2031)
8.2 Asia-Pacific Kidney (Renal) Fibrosis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Kidney (Renal) Fibrosis Market Size by Region (2020-2025)
8.4 Asia-Pacific Kidney (Renal) Fibrosis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Kidney (Renal) Fibrosis Market Size (2020-2031)
9.2 Latin America Kidney (Renal) Fibrosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Kidney (Renal) Fibrosis Market Size by Country (2020-2025)
9.4 Latin America Kidney (Renal) Fibrosis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kidney (Renal) Fibrosis Market Size (2020-2031)
10.2 Middle East & Africa Kidney (Renal) Fibrosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Kidney (Renal) Fibrosis Market Size by Country (2020-2025)
10.4 Middle East & Africa Kidney (Renal) Fibrosis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Kidney (Renal) Fibrosis Introduction
11.1.4 Merck Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Kidney (Renal) Fibrosis Introduction
11.2.4 Pfizer Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Kidney (Renal) Fibrosis Introduction
11.3.4 Roche Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.3.5 Roche Recent Development
11.4 InterMune
11.4.1 InterMune Company Details
11.4.2 InterMune Business Overview
11.4.3 InterMune Kidney (Renal) Fibrosis Introduction
11.4.4 InterMune Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.4.5 InterMune Recent Development
11.5 Galectin Therapeutics
11.5.1 Galectin Therapeutics Company Details
11.5.2 Galectin Therapeutics Business Overview
11.5.3 Galectin Therapeutics Kidney (Renal) Fibrosis Introduction
11.5.4 Galectin Therapeutics Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.5.5 Galectin Therapeutics Recent Development
11.6 La Jolla Pharmaceutical Company
11.6.1 La Jolla Pharmaceutical Company Company Details
11.6.2 La Jolla Pharmaceutical Company Business Overview
11.6.3 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Introduction
11.6.4 La Jolla Pharmaceutical Company Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.6.5 La Jolla Pharmaceutical Company Recent Development
11.7 ProMetic Life-Sciences Inc.
11.7.1 ProMetic Life-Sciences Inc. Company Details
11.7.2 ProMetic Life-Sciences Inc. Business Overview
11.7.3 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Introduction
11.7.4 ProMetic Life-Sciences Inc. Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.7.5 ProMetic Life-Sciences Inc. Recent Development
11.8 BioLine Rx Ltd
11.8.1 BioLine Rx Ltd Company Details
11.8.2 BioLine Rx Ltd Business Overview
11.8.3 BioLine Rx Ltd Kidney (Renal) Fibrosis Introduction
11.8.4 BioLine Rx Ltd Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.8.5 BioLine Rx Ltd Recent Development
11.9 Genzyme Corporation
11.9.1 Genzyme Corporation Company Details
11.9.2 Genzyme Corporation Business Overview
11.9.3 Genzyme Corporation Kidney (Renal) Fibrosis Introduction
11.9.4 Genzyme Corporation Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.9.5 Genzyme Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney (Renal) Fibrosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Angiotensin Converting enzyme (ACE) Inhibitors
1.2.3 Pirfenidone
1.2.4 Renin Inhibitors
1.2.5 Angiotensin II Receptor Blockers (ARBs)
1.2.6 Vasopeptidase Inhibitors
1.3 Market by Application
1.3.1 Global Kidney (Renal) Fibrosis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Kidney (Renal) Fibrosis Market Perspective (2020-2031)
2.2 Global Kidney (Renal) Fibrosis Growth Trends by Region
2.2.1 Global Kidney (Renal) Fibrosis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Kidney (Renal) Fibrosis Historic Market Size by Region (2020-2025)
2.2.3 Kidney (Renal) Fibrosis Forecasted Market Size by Region (2026-2031)
2.3 Kidney (Renal) Fibrosis Market Dynamics
2.3.1 Kidney (Renal) Fibrosis Industry Trends
2.3.2 Kidney (Renal) Fibrosis Market Drivers
2.3.3 Kidney (Renal) Fibrosis Market Challenges
2.3.4 Kidney (Renal) Fibrosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kidney (Renal) Fibrosis Players by Revenue
3.1.1 Global Top Kidney (Renal) Fibrosis Players by Revenue (2020-2025)
3.1.2 Global Kidney (Renal) Fibrosis Revenue Market Share by Players (2020-2025)
3.2 Global Kidney (Renal) Fibrosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Kidney (Renal) Fibrosis Revenue
3.4 Global Kidney (Renal) Fibrosis Market Concentration Ratio
3.4.1 Global Kidney (Renal) Fibrosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney (Renal) Fibrosis Revenue in 2024
3.5 Global Key Players of Kidney (Renal) Fibrosis Head office and Area Served
3.6 Global Key Players of Kidney (Renal) Fibrosis, Product and Application
3.7 Global Key Players of Kidney (Renal) Fibrosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney (Renal) Fibrosis Breakdown Data by Type
4.1 Global Kidney (Renal) Fibrosis Historic Market Size by Type (2020-2025)
4.2 Global Kidney (Renal) Fibrosis Forecasted Market Size by Type (2026-2031)
5 Kidney (Renal) Fibrosis Breakdown Data by Application
5.1 Global Kidney (Renal) Fibrosis Historic Market Size by Application (2020-2025)
5.2 Global Kidney (Renal) Fibrosis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Kidney (Renal) Fibrosis Market Size (2020-2031)
6.2 North America Kidney (Renal) Fibrosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Kidney (Renal) Fibrosis Market Size by Country (2020-2025)
6.4 North America Kidney (Renal) Fibrosis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Kidney (Renal) Fibrosis Market Size (2020-2031)
7.2 Europe Kidney (Renal) Fibrosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Kidney (Renal) Fibrosis Market Size by Country (2020-2025)
7.4 Europe Kidney (Renal) Fibrosis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Kidney (Renal) Fibrosis Market Size (2020-2031)
8.2 Asia-Pacific Kidney (Renal) Fibrosis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Kidney (Renal) Fibrosis Market Size by Region (2020-2025)
8.4 Asia-Pacific Kidney (Renal) Fibrosis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Kidney (Renal) Fibrosis Market Size (2020-2031)
9.2 Latin America Kidney (Renal) Fibrosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Kidney (Renal) Fibrosis Market Size by Country (2020-2025)
9.4 Latin America Kidney (Renal) Fibrosis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kidney (Renal) Fibrosis Market Size (2020-2031)
10.2 Middle East & Africa Kidney (Renal) Fibrosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Kidney (Renal) Fibrosis Market Size by Country (2020-2025)
10.4 Middle East & Africa Kidney (Renal) Fibrosis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Kidney (Renal) Fibrosis Introduction
11.1.4 Merck Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Kidney (Renal) Fibrosis Introduction
11.2.4 Pfizer Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Kidney (Renal) Fibrosis Introduction
11.3.4 Roche Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.3.5 Roche Recent Development
11.4 InterMune
11.4.1 InterMune Company Details
11.4.2 InterMune Business Overview
11.4.3 InterMune Kidney (Renal) Fibrosis Introduction
11.4.4 InterMune Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.4.5 InterMune Recent Development
11.5 Galectin Therapeutics
11.5.1 Galectin Therapeutics Company Details
11.5.2 Galectin Therapeutics Business Overview
11.5.3 Galectin Therapeutics Kidney (Renal) Fibrosis Introduction
11.5.4 Galectin Therapeutics Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.5.5 Galectin Therapeutics Recent Development
11.6 La Jolla Pharmaceutical Company
11.6.1 La Jolla Pharmaceutical Company Company Details
11.6.2 La Jolla Pharmaceutical Company Business Overview
11.6.3 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Introduction
11.6.4 La Jolla Pharmaceutical Company Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.6.5 La Jolla Pharmaceutical Company Recent Development
11.7 ProMetic Life-Sciences Inc.
11.7.1 ProMetic Life-Sciences Inc. Company Details
11.7.2 ProMetic Life-Sciences Inc. Business Overview
11.7.3 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Introduction
11.7.4 ProMetic Life-Sciences Inc. Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.7.5 ProMetic Life-Sciences Inc. Recent Development
11.8 BioLine Rx Ltd
11.8.1 BioLine Rx Ltd Company Details
11.8.2 BioLine Rx Ltd Business Overview
11.8.3 BioLine Rx Ltd Kidney (Renal) Fibrosis Introduction
11.8.4 BioLine Rx Ltd Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.8.5 BioLine Rx Ltd Recent Development
11.9 Genzyme Corporation
11.9.1 Genzyme Corporation Company Details
11.9.2 Genzyme Corporation Business Overview
11.9.3 Genzyme Corporation Kidney (Renal) Fibrosis Introduction
11.9.4 Genzyme Corporation Revenue in Kidney (Renal) Fibrosis Business (2020-2025)
11.9.5 Genzyme Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Kidney (Renal) Fibrosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Angiotensin Converting enzyme (ACE) Inhibitors
Table 3. Key Players of Pirfenidone
Table 4. Key Players of Renin Inhibitors
Table 5. Key Players of Angiotensin II Receptor Blockers (ARBs)
Table 6. Key Players of Vasopeptidase Inhibitors
Table 7. Global Kidney (Renal) Fibrosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Kidney (Renal) Fibrosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Kidney (Renal) Fibrosis Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Kidney (Renal) Fibrosis Market Share by Region (2020-2025)
Table 11. Global Kidney (Renal) Fibrosis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Kidney (Renal) Fibrosis Market Share by Region (2026-2031)
Table 13. Kidney (Renal) Fibrosis Market Trends
Table 14. Kidney (Renal) Fibrosis Market Drivers
Table 15. Kidney (Renal) Fibrosis Market Challenges
Table 16. Kidney (Renal) Fibrosis Market Restraints
Table 17. Global Kidney (Renal) Fibrosis Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Kidney (Renal) Fibrosis Market Share by Players (2020-2025)
Table 19. Global Top Kidney (Renal) Fibrosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney (Renal) Fibrosis as of 2024)
Table 20. Ranking of Global Top Kidney (Renal) Fibrosis Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Kidney (Renal) Fibrosis Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Kidney (Renal) Fibrosis, Headquarters and Area Served
Table 23. Global Key Players of Kidney (Renal) Fibrosis, Product and Application
Table 24. Global Key Players of Kidney (Renal) Fibrosis, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Kidney (Renal) Fibrosis Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Kidney (Renal) Fibrosis Revenue Market Share by Type (2020-2025)
Table 28. Global Kidney (Renal) Fibrosis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Kidney (Renal) Fibrosis Revenue Market Share by Type (2026-2031)
Table 30. Global Kidney (Renal) Fibrosis Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Kidney (Renal) Fibrosis Revenue Market Share by Application (2020-2025)
Table 32. Global Kidney (Renal) Fibrosis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Kidney (Renal) Fibrosis Revenue Market Share by Application (2026-2031)
Table 34. North America Kidney (Renal) Fibrosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Kidney (Renal) Fibrosis Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Kidney (Renal) Fibrosis Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Kidney (Renal) Fibrosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Kidney (Renal) Fibrosis Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Kidney (Renal) Fibrosis Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Kidney (Renal) Fibrosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Kidney (Renal) Fibrosis Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Kidney (Renal) Fibrosis Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Kidney (Renal) Fibrosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Kidney (Renal) Fibrosis Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Kidney (Renal) Fibrosis Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Kidney (Renal) Fibrosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Kidney (Renal) Fibrosis Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Kidney (Renal) Fibrosis Market Size by Country (2026-2031) & (US$ Million)
Table 49. Merck Company Details
Table 50. Merck Business Overview
Table 51. Merck Kidney (Renal) Fibrosis Product
Table 52. Merck Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 53. Merck Recent Development
Table 54. Pfizer Company Details
Table 55. Pfizer Business Overview
Table 56. Pfizer Kidney (Renal) Fibrosis Product
Table 57. Pfizer Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Roche Company Details
Table 60. Roche Business Overview
Table 61. Roche Kidney (Renal) Fibrosis Product
Table 62. Roche Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 63. Roche Recent Development
Table 64. InterMune Company Details
Table 65. InterMune Business Overview
Table 66. InterMune Kidney (Renal) Fibrosis Product
Table 67. InterMune Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 68. InterMune Recent Development
Table 69. Galectin Therapeutics Company Details
Table 70. Galectin Therapeutics Business Overview
Table 71. Galectin Therapeutics Kidney (Renal) Fibrosis Product
Table 72. Galectin Therapeutics Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 73. Galectin Therapeutics Recent Development
Table 74. La Jolla Pharmaceutical Company Company Details
Table 75. La Jolla Pharmaceutical Company Business Overview
Table 76. La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Product
Table 77. La Jolla Pharmaceutical Company Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 78. La Jolla Pharmaceutical Company Recent Development
Table 79. ProMetic Life-Sciences Inc. Company Details
Table 80. ProMetic Life-Sciences Inc. Business Overview
Table 81. ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Product
Table 82. ProMetic Life-Sciences Inc. Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 83. ProMetic Life-Sciences Inc. Recent Development
Table 84. BioLine Rx Ltd Company Details
Table 85. BioLine Rx Ltd Business Overview
Table 86. BioLine Rx Ltd Kidney (Renal) Fibrosis Product
Table 87. BioLine Rx Ltd Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 88. BioLine Rx Ltd Recent Development
Table 89. Genzyme Corporation Company Details
Table 90. Genzyme Corporation Business Overview
Table 91. Genzyme Corporation Kidney (Renal) Fibrosis Product
Table 92. Genzyme Corporation Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 93. Genzyme Corporation Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. Kidney (Renal) Fibrosis Picture
Figure 2. Global Kidney (Renal) Fibrosis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Kidney (Renal) Fibrosis Market Share by Type: 2024 VS 2031
Figure 4. Angiotensin Converting enzyme (ACE) Inhibitors Features
Figure 5. Pirfenidone Features
Figure 6. Renin Inhibitors Features
Figure 7. Angiotensin II Receptor Blockers (ARBs) Features
Figure 8. Vasopeptidase Inhibitors Features
Figure 9. Global Kidney (Renal) Fibrosis Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Kidney (Renal) Fibrosis Market Share by Application: 2024 VS 2031
Figure 11. Research Center Case Studies
Figure 12. Hospital Case Studies
Figure 13. Clinic Case Studies
Figure 14. Kidney (Renal) Fibrosis Report Years Considered
Figure 15. Global Kidney (Renal) Fibrosis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Kidney (Renal) Fibrosis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Kidney (Renal) Fibrosis Market Share by Region: 2024 VS 2031
Figure 18. Global Kidney (Renal) Fibrosis Market Share by Players in 2024
Figure 19. Global Top Kidney (Renal) Fibrosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney (Renal) Fibrosis as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Kidney (Renal) Fibrosis Revenue in 2024
Figure 21. North America Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Kidney (Renal) Fibrosis Market Share by Country (2020-2031)
Figure 23. United States Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Kidney (Renal) Fibrosis Market Share by Country (2020-2031)
Figure 27. Germany Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Kidney (Renal) Fibrosis Market Share by Region (2020-2031)
Figure 35. China Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Kidney (Renal) Fibrosis Market Share by Country (2020-2031)
Figure 43. Mexico Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Kidney (Renal) Fibrosis Market Share by Country (2020-2031)
Figure 47. Turkey Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Merck Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 52. Roche Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 53. InterMune Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 54. Galectin Therapeutics Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 55. La Jolla Pharmaceutical Company Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 56. ProMetic Life-Sciences Inc. Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 57. BioLine Rx Ltd Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 58. Genzyme Corporation Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Kidney (Renal) Fibrosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Angiotensin Converting enzyme (ACE) Inhibitors
Table 3. Key Players of Pirfenidone
Table 4. Key Players of Renin Inhibitors
Table 5. Key Players of Angiotensin II Receptor Blockers (ARBs)
Table 6. Key Players of Vasopeptidase Inhibitors
Table 7. Global Kidney (Renal) Fibrosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Kidney (Renal) Fibrosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Kidney (Renal) Fibrosis Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Kidney (Renal) Fibrosis Market Share by Region (2020-2025)
Table 11. Global Kidney (Renal) Fibrosis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Kidney (Renal) Fibrosis Market Share by Region (2026-2031)
Table 13. Kidney (Renal) Fibrosis Market Trends
Table 14. Kidney (Renal) Fibrosis Market Drivers
Table 15. Kidney (Renal) Fibrosis Market Challenges
Table 16. Kidney (Renal) Fibrosis Market Restraints
Table 17. Global Kidney (Renal) Fibrosis Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Kidney (Renal) Fibrosis Market Share by Players (2020-2025)
Table 19. Global Top Kidney (Renal) Fibrosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney (Renal) Fibrosis as of 2024)
Table 20. Ranking of Global Top Kidney (Renal) Fibrosis Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Kidney (Renal) Fibrosis Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Kidney (Renal) Fibrosis, Headquarters and Area Served
Table 23. Global Key Players of Kidney (Renal) Fibrosis, Product and Application
Table 24. Global Key Players of Kidney (Renal) Fibrosis, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Kidney (Renal) Fibrosis Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Kidney (Renal) Fibrosis Revenue Market Share by Type (2020-2025)
Table 28. Global Kidney (Renal) Fibrosis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Kidney (Renal) Fibrosis Revenue Market Share by Type (2026-2031)
Table 30. Global Kidney (Renal) Fibrosis Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Kidney (Renal) Fibrosis Revenue Market Share by Application (2020-2025)
Table 32. Global Kidney (Renal) Fibrosis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Kidney (Renal) Fibrosis Revenue Market Share by Application (2026-2031)
Table 34. North America Kidney (Renal) Fibrosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Kidney (Renal) Fibrosis Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Kidney (Renal) Fibrosis Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Kidney (Renal) Fibrosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Kidney (Renal) Fibrosis Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Kidney (Renal) Fibrosis Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Kidney (Renal) Fibrosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Kidney (Renal) Fibrosis Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Kidney (Renal) Fibrosis Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Kidney (Renal) Fibrosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Kidney (Renal) Fibrosis Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Kidney (Renal) Fibrosis Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Kidney (Renal) Fibrosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Kidney (Renal) Fibrosis Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Kidney (Renal) Fibrosis Market Size by Country (2026-2031) & (US$ Million)
Table 49. Merck Company Details
Table 50. Merck Business Overview
Table 51. Merck Kidney (Renal) Fibrosis Product
Table 52. Merck Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 53. Merck Recent Development
Table 54. Pfizer Company Details
Table 55. Pfizer Business Overview
Table 56. Pfizer Kidney (Renal) Fibrosis Product
Table 57. Pfizer Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Roche Company Details
Table 60. Roche Business Overview
Table 61. Roche Kidney (Renal) Fibrosis Product
Table 62. Roche Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 63. Roche Recent Development
Table 64. InterMune Company Details
Table 65. InterMune Business Overview
Table 66. InterMune Kidney (Renal) Fibrosis Product
Table 67. InterMune Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 68. InterMune Recent Development
Table 69. Galectin Therapeutics Company Details
Table 70. Galectin Therapeutics Business Overview
Table 71. Galectin Therapeutics Kidney (Renal) Fibrosis Product
Table 72. Galectin Therapeutics Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 73. Galectin Therapeutics Recent Development
Table 74. La Jolla Pharmaceutical Company Company Details
Table 75. La Jolla Pharmaceutical Company Business Overview
Table 76. La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Product
Table 77. La Jolla Pharmaceutical Company Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 78. La Jolla Pharmaceutical Company Recent Development
Table 79. ProMetic Life-Sciences Inc. Company Details
Table 80. ProMetic Life-Sciences Inc. Business Overview
Table 81. ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Product
Table 82. ProMetic Life-Sciences Inc. Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 83. ProMetic Life-Sciences Inc. Recent Development
Table 84. BioLine Rx Ltd Company Details
Table 85. BioLine Rx Ltd Business Overview
Table 86. BioLine Rx Ltd Kidney (Renal) Fibrosis Product
Table 87. BioLine Rx Ltd Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 88. BioLine Rx Ltd Recent Development
Table 89. Genzyme Corporation Company Details
Table 90. Genzyme Corporation Business Overview
Table 91. Genzyme Corporation Kidney (Renal) Fibrosis Product
Table 92. Genzyme Corporation Revenue in Kidney (Renal) Fibrosis Business (2020-2025) & (US$ Million)
Table 93. Genzyme Corporation Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. Kidney (Renal) Fibrosis Picture
Figure 2. Global Kidney (Renal) Fibrosis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Kidney (Renal) Fibrosis Market Share by Type: 2024 VS 2031
Figure 4. Angiotensin Converting enzyme (ACE) Inhibitors Features
Figure 5. Pirfenidone Features
Figure 6. Renin Inhibitors Features
Figure 7. Angiotensin II Receptor Blockers (ARBs) Features
Figure 8. Vasopeptidase Inhibitors Features
Figure 9. Global Kidney (Renal) Fibrosis Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Kidney (Renal) Fibrosis Market Share by Application: 2024 VS 2031
Figure 11. Research Center Case Studies
Figure 12. Hospital Case Studies
Figure 13. Clinic Case Studies
Figure 14. Kidney (Renal) Fibrosis Report Years Considered
Figure 15. Global Kidney (Renal) Fibrosis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Kidney (Renal) Fibrosis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Kidney (Renal) Fibrosis Market Share by Region: 2024 VS 2031
Figure 18. Global Kidney (Renal) Fibrosis Market Share by Players in 2024
Figure 19. Global Top Kidney (Renal) Fibrosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney (Renal) Fibrosis as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Kidney (Renal) Fibrosis Revenue in 2024
Figure 21. North America Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Kidney (Renal) Fibrosis Market Share by Country (2020-2031)
Figure 23. United States Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Kidney (Renal) Fibrosis Market Share by Country (2020-2031)
Figure 27. Germany Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Kidney (Renal) Fibrosis Market Share by Region (2020-2031)
Figure 35. China Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Kidney (Renal) Fibrosis Market Share by Country (2020-2031)
Figure 43. Mexico Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Kidney (Renal) Fibrosis Market Share by Country (2020-2031)
Figure 47. Turkey Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Kidney (Renal) Fibrosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Merck Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 52. Roche Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 53. InterMune Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 54. Galectin Therapeutics Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 55. La Jolla Pharmaceutical Company Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 56. ProMetic Life-Sciences Inc. Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 57. BioLine Rx Ltd Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 58. Genzyme Corporation Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232